All In Biotech

Drug Trial Radar · NCT06218771

A Study of TQB3454 Tablets in Patients With Blood Tumors

A Phase Ib Clinical Trial of TQB3454 Tablets in Patients With Blood Tumors

Last checked: Nov 19, 2026Latest source record: Jan 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

80

Planned (sponsor's estimate)

Start

Jul 10, 2023

Primary completion

Jun 2025

Study completion Dec 2025

Sponsor

Sponsor type
Industry
First posted
Jan 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical trial is to evaluate the safety of TQB3454 tablets in patients with acute myeloid leukemia and myelodysplastic syndrome, and determine the phase II recommended dose.

Conditions

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes

Interventions

  • TQB3454 TabletsDrug

    TQB3454 Tablets is a selective isocitrate dehydrogenase 1 (IDH1) mutation inhibitor

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The rate of all adverse events (AEs), serious adverse events (SAEs)Time frame: Up to 80 weeks
  2. The severity of all adverse events (AEs), serious adverse events (SAEs)Time frame: Up to 80 weeks
  3. Incidence of abnormal laboratory valuesTime frame: Up to 80 weeks

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China · Recruiting

  • Cangzhou people's Hospital

    Cangzhou, Hebei, China · Recruiting

  • The Affiliated Hospital of Chengde Medical College

    Chengde, Hebei, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital Tongji Medical College of Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China · Recruiting

  • Wuxi People's Hospital

    Wuxi, Jiangsu, China · Recruiting

  • Affiliated Hospital of Binzhou Medical College

    Binzhou, Shandong, China · Recruiting

  • Yantai Mountain Hospital

    Yantai, Shandong, China · Recruiting

  • Yantai Yuhuangding Hospital

    Yantai, Shandong, China · Recruiting

  • Shanghai Tongren Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Huashan Hospital affiliated to Fudan University

    Shanghai, Shanghai Municipality, China · Recruiting

  • Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, China · Recruiting

  • Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China · Recruiting

  • Hospital of Hematology, Chinese Academy of Medical Sciences

    Tianjin, Tianjin Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.